КЛИНИКО-ИММУНОЛОГИЧЕСКИЕ ПРЕДИКТОРЫ ТРОМБОТИЧЕСКИХ ОСЛОЖНЕНИЙ ПРИ ОСТРОМ КОРОНАРНОМ СИНДРОМЕ
Jild 4 son 63 (2026) 89-90
Annotatsiya
Kalit soʻzlar:
Iqtiboslar
Libby P. Inflammation in atherosclerosis // Arterioscler. Thromb. Vasc. Biol. – 2012. – Vol. 32(9). – P. 2045–2051.
Ridker P.M., Everett B.M., Thuren T. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease (CANTOS) // N. Engl. J. Med. – 2017. – Vol. 377. – P. 1119–1131.
Engelmann B., Massberg S. Thrombosis as an intravascular effector of innate immunity // Nat. Rev. Immunol. – 2013. – Vol. 13. – P. 34–45.
Collet J.P., Thiele H., Barbato E. et al. 2020 ESC Guidelines for the management of acute coronary syndromes // Eur. Heart J. – 2021. – Vol. 42(14). – P. 1289–1367.
Oʻquvchilar geografiyasi
Yuklab olishlar
Nashr qilingan
Son
Boʻlim
Litsenziya
##submission.copyrightStatement##
##submission.license.cc.by4.footer##Iqtibos keltirish tartibi